Literature DB >> 2148977

Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease.

A A Hislop1, S G Haworth.   

Abstract

Light microscopic morphometric techniques have been used to study the lungs in 17 infants and young children aged 2 weeks to 3.5 years who were born prematurely, developed hyaline membrane disease (HMD), and died with chronic lung disease. They were divided into three groups. In group 1 the babies died without recovering from their initial illness at age 2-13 weeks. In group 2 they died, aged 4-15 months, having recovered from the neonatal illness. Neither group showed clinical or pathological evidence of cor pulmonale (CP). In group 3 children died aged 6 months to 3.5 years with CP. None of the 17 patients had classical fibrotic bronchopulmonary dysplasia (BPD) but all had a reduced alveolar number and an increase in bronchial smooth muscle in small airways. All three groups showed an increase in pulmonary arterial medial thickness (P less than 0.001). In group 1 the appearance of the arteries suggested persistance of the fetal state. In group 2 and 3 the vessels had a more mature structure; in group 3 a marked secondary increase in muscularity was found, approaching the thickness seen in fetal life. In groups 2 and 3 muscle extended into smaller arteries than normal. Vein wall thickness was increased. The alveolar to arterial ratio was normal, the alveolar number was reduced, therefore the total number of arteries was reduced in all three groups. Thus, babies who recover from HMD may have significant vascular abnormalities in the absence of CP; conversely, CP if present, does not mean advanced obliterative pulmonary vascular disease. Thus, pulmonary vascular morphology does not correlate with the presence or absence of CP.

Entities:  

Mesh:

Year:  1990        PMID: 2148977     DOI: 10.1002/ppul.1950090306

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  31 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

2.  Changes in pulmonary arterial pressure in preterm infants with chronic lung disease.

Authors:  N V Subhedar; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

Review 3.  Airway and blood vessel interaction during lung development.

Authors:  Alison A Hislop
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

4.  Endothelial nitric oxide synthase in hypoxic newborn porcine pulmonary vessels.

Authors:  A A Hislop; D R Springall; H Oliveira; J S Pollock; J M Polak; S G Haworth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

Review 5.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

6.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

7.  Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; D Dunbar Ivy; Steven H Abman
Journal:  J Pediatr       Date:  2008-10-31       Impact factor: 4.406

Review 8.  Progress in understanding the pathogenesis of BPD using the baboon and sheep models.

Authors:  Kurt H Albertine
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 9.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Sara K Berkelhamer; Karen K Mestan; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.